Cargando…

The curious case of a woman with two BRCA1 mutations in trans

Detalles Bibliográficos
Autores principales:	Scott, Rodney J, Wong-Brown, Michelle, McPhillips, Mary, Dooley, Susan, Spigelman, Allan, Gleeson, Margaret, Meldrum, Cliff
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674879/ http://dx.doi.org/10.1186/1897-4287-13-S2-A11

Ejemplares similares

When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans
por: Wong-Brown, Michelle, et al.
Publicado: (2016)

Correction: When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans
por: Wong-Brown, Michelle, et al.
Publicado: (2022)

Deletion Mutations in an Australian Series of HNPCC Patients
por: McPhillips, Mary, et al.
Publicado: (2005)

MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer
por: Talseth-Palmer, Bente A, et al.
Publicado: (2010)

Frequency of the Common MYH Mutations (G382D and Y165C) in MMR Mutation Positive and Negative HNPCC Patients
por: Ashton, Katie A, et al.
Publicado: (2005)

A Comparison Between Denaturing Gradient Gel Electrophoresis and Denaturing High Performance Liquid Chromatography in Detecting Mutations in Genes Associated with Hereditary Non-Polyposis Colorectal Cancer (HNPCC) and the Identification of 9 New Mutations Previously Unidentified by DGGE
por: Meldrum, Cliff J, et al.
Publicado: (2003)

The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria
por: Ashton, Katie A, et al.
Publicado: (2006)

Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts
por: Talseth-Palmer, Bente A, et al.
Publicado: (2012)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

A Curious Case of Parasitic Fibroid in a Postmenopausal Woman
por: Barik, Archana, et al.
Publicado: (2022)

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
por: Wappenschmidt, B, et al.
Publicado: (2001)

Germline Missense Changes in the APC Gene and Their Relationship to Disease
por: Scott, Rodney J, et al.
Publicado: (2004)

A tale of excess: the curious case of the woman with 1447 emergency visits
por: Sagué Vilavella, M., et al.
Publicado: (2023)

Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer
por: Martínez-Ferrandis, JI, et al.
Publicado: (2000)

Targeted next‐generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families
por: Talseth‐Palmer, Bente A., et al.
Publicado: (2016)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival
por: Bolton, KL, et al.
Publicado: (2012)

Missense Mutations in Cancer Predisposing Genes: Can We Make Sense of Them?
por: Scott, Rodney J, et al.
Publicado: (2005)

Genetics of Ribosomal Proteins: “Curiouser and Curiouser”
por: Terzian, Tamara, et al.
Publicado: (2013)

Selenium and genotypes as marker of risk in BRCA1 mutation carriers
por: Jaworska, K, et al.
Publicado: (2012)

BRCA1 mutation in the Triple- Negative Breast Cancer Group
por: Maksimenko, Jelena, et al.
Publicado: (2012)

The contribution of LARGE genomic rearrangements of BRCA1 and BRCA2 gene mutations in breast and ovarian cancer families in a clinical cohort
por: Sawyer, S, et al.
Publicado: (2012)

BRCA germline mutation test for all woman with ovarian cancer?
por: Paradiso, A. V., et al.
Publicado: (2019)

Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations
por: Ghimenti, C, et al.
Publicado: (2000)

One test to identify 50% of all Norwegian BRCA1 mutations
por: Møller, P, et al.
Publicado: (2000)

Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP
por: Kringen, P, et al.
Publicado: (2000)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
por: Byrski, T, et al.
Publicado: (2012)

Lynch syndrome mutation spectrum in New South Wales, Australia, including 55 novel mutations
por: Sjursen, Wenche, et al.
Publicado: (2016)

BRCA2 interacting proteins
por: Vidarsson, H, et al.
Publicado: (2000)

BRCA1 testing in Lithuania
por: Janavicius, Ramunas
Publicado: (2012)

Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2
por: Johnson, SM, et al.
Publicado: (2000)

Genetic insights into breast cancer risk
por: Wong-Brown, Michelle, et al.
Publicado: (2015)

tranSMART
por: Bierkens, Mariska, et al.
Publicado: (2015)

BRCA1 mutation analysis in breast and ovarian cancer families from Greece
por: Konstantopoulou, I, et al.
Publicado: (2000)

Impact of BRCA1 mutation on survival after early onset breast cancer
por: Huzarski, T, et al.
Publicado: (2012)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

Estrogen receptor transcription and transactivation: Genetic modifiers of cancer risks conferred by BRCA1 and BRCA2
por: Devilee, P
Publicado: (2001)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

Searching for BRCA3 by exome sequencing
por: Makunin, I, et al.
Publicado: (2012)

P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers
por: Sensi, E, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_4030tbof12d8hinfj5cl9ajniv